Skip to content
Screener

AYTU BioPharma, Inc. AYTU Q3 2025 earnings

Reported November 13, 2025 · After market close

Revenue$13.9MBeat by $1.3M
EPS-$0.08Miss by $0.02
Revenue estimate$12.6M
EPS estimate-$0.06

Next report

Sep 29, 2026 (in a month)
Revenue estimate$12.3M
EPS estimate-$0.29

FAQ

When did AYTU BioPharma, Inc. report Q3 2025 earnings?
AYTU BioPharma, Inc. (AYTU) reported Q3 2025 earnings on November 13, 2025 after market close.
What were AYTU BioPharma, Inc.'s Q3 2025 revenue and EPS?
AYTU BioPharma, Inc. reported revenue of $13.9M and eps of $-0.08 for Q3 2025.
Did AYTU BioPharma, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $12.6M by $1.3M. EPS missed the consensus estimate of $-0.06 by $0.02.
How did AYTU BioPharma, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 16.2% from $16.6M a year earlier and eps grew 60.0% from $-0.20.
Where can I find AYTU BioPharma, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-034822) and the 10-Q periodic report (0001437749-25-034825) directly on SEC EDGAR. The filing index links above go to sec.gov.